CSIMarket
 


Alaunos Therapeutics Inc   (TCRT)
Other Ticker:  
 

Alaunos Therapeutics Inc 's Tangible Leverage Ratio

TCRT's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




TCRT Tangible Leverage Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Tangible Equity Change -53.26 % -54.49 % -53.5 % -59.94 % -57.96 %
Y / Y Total Liabilities Change -21.8 % 82.6 % 57.11 % 75.48 % 146.67 %
Tangible Leverage Ratio MRQ 1.1 0.84 0.73 0.63 0.66
Overall Ranking # # # # #
Seq. Tangible Equity Change -20.08 % -18.2 % -15.39 % -15.5 % -22.17 %
Seq. Total Liabilities Change 4.39 % -5.9 % -2.55 % -18.3 % 143.75 %



Tangible Leverage Ratio third quarter 2022 Comment
Due to net new borrowings of 4.39%, Tangible Leverage Ratio detoriated to 1.1, above company's average Tangible Leverage Ratio.

Within Major Pharmaceutical Preparations industry Alaunos Therapeutics Inc achieved lowest Tangible Leverage Ratio. While total ranking remained unchanged compare to previous quarter at no. .

Explain Tangible Leverage Ratio?
What is TCRT Market Share?
Tangible Leverage Ratio third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Tangible Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Alaunos Therapeutics Inc 's Tangible Equity $ 32 Millions Visit TCRT's Balance sheet
Alaunos Therapeutics Inc 's Total Liabilities $ 35 Millions Visit TCRT's Balance sheet
Source of TCRT's Sales Visit TCRT's Sales by Geography


Cumulative Alaunos Therapeutics Inc 's Tangible Leverage Ratio

TCRT's Tangible Leverage Ratio for the trailling 12 Months